Citigroup Inc ENLIVEN THERAPEUTICS INC Transaction History

Citigroup Inc

  • $196 Billion
  • Q2 2025
Number of Shares
18,139
Previous 30,839 41.18%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
N/A
-12,700 Reduced 41.18%
18,139 $0
Q1 2025

May 12, 2025
SELL
N/A
-2,709 Reduced 8.07%
30,839 $0
Q4 2024

Feb 12, 2025
BUY
N/A
4,650 Added 16.09%
33,548 $0
Q3 2024

Nov 12, 2024
BUY
N/A
18,296 Added 172.57%
28,898 $0
Q2 2024

Aug 12, 2024
BUY
N/A
2,769 Added 35.35%
10,602 $0
Q1 2024

May 10, 2024
BUY
N/A
427 Added 5.77%
7,833 $0
Q4 2023

Feb 09, 2024
BUY
N/A
4,059 Added 121.27%
7,406 $0
Q3 2023

Nov 09, 2023
SELL
N/A
-7,476 Reduced 69.08%
3,347 $0
Q2 2023

Aug 10, 2023
SELL
N/A
-440 Reduced 3.91%
10,823 $0
Q1 2023

May 11, 2023
BUY
N/A
11,263 New
11,263 $0
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email